XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Nov. 30, 2021
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Repurchase of shares, value         $ 2,482,286      
Number of restricted shares           12,000    
Fair value of restricted shares           $ 63,000    
Expected shares vested   6,000       6,000    
Common stock, shares authorized   25,000,000       25,000,000   25,000,000
Common stock, shares issued   10,869,040       10,869,040   10,857,040
Common stock, shares outstanding   10,869,040       10,869,040   10,857,040
Weighted average exercise price   $ 6.21       $ 6.21   $ 6.46
General and Administrative Expense [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Restricted stock expense   $ 32,000       $ 32,000    
Equity Option [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Issuance of stock       26,093     26,093  
Common stock issued from option exercises, shares       32,538     32,538  
Common Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Repurchase of shares         353,667      
Repurchase of shares, value         $ 36      
Issuance of stock       0     95,779  
Common stock issued from option exercises, shares       26,093        
Proceeds from warrants exercise       $ 300,000     $ 300,000  
Exercise price       $ 3.13     $ 3.13  
Number of restricted shares     12,000          
Options were exercisable   860,004       860,004    
Weighted average exercise price, exercisable   $ 6.23       $ 6.23    
Common Stock [Member] | Director [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Repurchase of shares 7,000,000     0     353,667  
Repurchase of shares, value       $ 2,482,000     $ 2,482,000  
Warrant [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Issuance of stock   0   0   0 95,779  
Warrants to purchase shares of common stock   177,998       177,998    
Weighted average exercise price   $ 9.27       $ 9.27    
Warrant [Member] | Minimum [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Expiration date of warrants           Mar. 07, 2024    
Warrant [Member] | Maximum [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Expiration date of warrants           Jun. 10, 2025